Boundless Bio, Inc.BOLDNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank77
3Y CAGR-5.3%
5Y CAGR-36.2%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-5.3%/yr
Quarterly compound
5Y CAGR
-36.2%/yr
Recent acceleration
Percentile
P77
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.57% |
| Q3 2025 | 11.21% |
| Q2 2025 | 1.61% |
| Q1 2025 | 5.13% |
| Q4 2024 | 2.34% |
| Q3 2024 | 3.49% |
| Q2 2024 | -14.86% |
| Q1 2024 | -22.38% |
| Q4 2023 | 7.74% |
| Q3 2023 | -7.11% |
| Q2 2023 | -15.50% |
| Q1 2023 | -0.12% |
| Q4 2022 | 8.90% |
| Q3 2022 | 0.00% |
| Q3 2019 | -48.35% |
| Q2 2019 | -90.83% |
| Q1 2019 | 61.43% |
| Q4 2018 | -38.85% |
| Q3 2018 | -63.92% |
| Q2 2018 | -123.55% |
| Q1 2018 | 71.66% |
| Q4 2017 | -40.55% |
| Q3 2017 | -61.36% |
| Q2 2017 | -125.19% |
| Q1 2017 | 69.61% |
| Q4 2016 | -49.32% |
| Q3 2016 | 0.00% |